LifeMD (NASDAQ:LFMD – Get Free Report) will announce its earnings results after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.13) per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.
LifeMD (NASDAQ:LFMD – Get Free Report) last announced its quarterly earnings results on Monday, March 11th. The company reported ($0.12) EPS for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.02. The firm had revenue of $44.86 million for the quarter, compared to the consensus estimate of $40.65 million. On average, analysts expect LifeMD to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
LifeMD Stock Up 0.2 %
Shares of LFMD opened at $12.51 on Monday. LifeMD has a 1 year low of $1.46 and a 1 year high of $12.80. The company has a quick ratio of 1.15, a current ratio of 1.22 and a debt-to-equity ratio of 3.22. The business’s 50 day simple moving average is $9.92 and its 200-day simple moving average is $7.97.
Wall Street Analyst Weigh In
Read Our Latest Report on LifeMD
LifeMD Company Profile
LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.
Read More
- Five stocks we like better than LifeMD
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 3 Value Stocks You Can Buy Before They Become Big
- What is a Dividend King?
- Chinese Stocks Stage Impressive Rebound
- Why Invest in 5G? How to Invest in 5G Stocks
- Coca-Cola Stock Analysis: Key Insights and Trends
Receive News & Ratings for LifeMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeMD and related companies with MarketBeat.com's FREE daily email newsletter.